ENDRA Life Sciences Inc. (NDRA)
undefined
undefined%
At close: undefined
4.27
0.71%
After-hours Dec 13, 2024, 04:42 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -10.06M -13.18M -11.23M -11.73M -13.31M -9.80M -5.38M -2.78M -2.28M -2.18M
Depreciation & Amortization 275.45K 234.26K 224.41K 165.25K 115.01K 68.32K 61.48K 64.94K 72.22K 37.24K
Stock-Based Compensation 996.43K 1.20M 1.44M 2.10M 1.40K 1.37K 1.00K 230.33K 309.84K 259.49K
Other Working Capital -239.11K 222.80K -566.44K -1.07M 651.83K 5.97M -71.21K 196.08K 203.09K -91.99K
Other Non-Cash Items 162.91K 1.39K -298.73K 2.33M 4.00M 2.38M 1.72M 909.50K 686.34K 639.12K
Deferred Income Tax - - - -2.10M -1.40K - - - 25.00K -
Change in Working Capital -923.32K -1.03M -1.26M -1.55M 597.83K -359.08K 298.66K 254.98K 343.07K -152.20K
Operating Cash Flow -9.55M -12.77M -11.12M -10.77M -8.59M -7.70M -3.30M -1.32M -842.73K -1.40M
Capital Expenditures -33.88K -202.58K -45.00K -51.33K -43.59K -100.00K -7.86K - -133.81K -275.37K
Acquisitions - - - - - - - - - -
Purchase of Investments - - - - - - - - - -
Sales Maturities Of Investments - - - - - - - - - -
Other Investing Acitivies 9.16K - - - - - - - - -
Investing Cash Flow -24.72K -202.58K -45.00K -51.33K -43.59K -100.00K -7.86K - -133.81K -275.37K
Debt Repayment - - - 337.08K 2.49M 935.30K 175.00K 1.44M - -
Common Stock Repurchased - - - - - - - - - -
Dividend Paid -840 -7.79K -121.07K -395.55K -4.22M - - - - -
Other Financial Acitivies 1.04M - 2.91M 5.15M 15.78M 7.74M 8.59M 5.00K - -
Financial Cash Flow 7.52M 8.40M 13.40M 11.88M 8.34M 8.67M 8.77M 1.44M 839.22K 1.75M
Net Cash Flow -2.06M -4.57M 2.23M 1.05M -297.17K 869.50K 5.46M 125.83K -137.31K 78.42K
Free Cash Flow -9.58M -12.97M -11.17M -10.82M -8.63M -7.80M -3.31M -1.32M -976.54K -1.67M